EP1333807A4 - Extended release erythromycin derivatives - Google Patents

Extended release erythromycin derivatives

Info

Publication number
EP1333807A4
EP1333807A4 EP01986972A EP01986972A EP1333807A4 EP 1333807 A4 EP1333807 A4 EP 1333807A4 EP 01986972 A EP01986972 A EP 01986972A EP 01986972 A EP01986972 A EP 01986972A EP 1333807 A4 EP1333807 A4 EP 1333807A4
Authority
EP
European Patent Office
Prior art keywords
extended release
erythromycin derivatives
release erythromycin
derivatives
extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01986972A
Other languages
German (de)
French (fr)
Other versions
EP1333807A2 (en
Inventor
Sandra E Wassink
Donald J Treacy Jr
Edward M Rudnic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MiddleBrook Pharmaceuticals Inc
Original Assignee
Advancis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancis Pharmaceutical Corp filed Critical Advancis Pharmaceutical Corp
Publication of EP1333807A2 publication Critical patent/EP1333807A2/en
Publication of EP1333807A4 publication Critical patent/EP1333807A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP01986972A 2000-10-13 2001-10-12 Extended release erythromycin derivatives Withdrawn EP1333807A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US689988 1991-04-23
US68998800A 2000-10-13 2000-10-13
PCT/US2001/032055 WO2002038577A2 (en) 2000-10-13 2001-10-12 Extended release erythromycin derivatives

Publications (2)

Publication Number Publication Date
EP1333807A2 EP1333807A2 (en) 2003-08-13
EP1333807A4 true EP1333807A4 (en) 2005-06-29

Family

ID=24770642

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01986972A Withdrawn EP1333807A4 (en) 2000-10-13 2001-10-12 Extended release erythromycin derivatives

Country Status (6)

Country Link
EP (1) EP1333807A4 (en)
JP (1) JP2004528272A (en)
AU (1) AU2002239232A1 (en)
CA (1) CA2425688A1 (en)
MX (1) MXPA03003146A (en)
WO (1) WO2002038577A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8795725B2 (en) * 2004-11-04 2014-08-05 Xenoport, Inc. GABA analog prodrug sustained release oral dosage forms

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019486A1 (en) * 1990-06-14 1991-12-26 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
US5707646A (en) * 1992-03-12 1998-01-13 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition
EP0826376A1 (en) * 1995-05-02 1998-03-04 Taisho Pharmaceutical Co. Ltd Composition for oral administration
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
WO2000054811A1 (en) * 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
WO2000069415A2 (en) * 1999-05-19 2000-11-23 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Melt granulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
JPS49107855A (en) * 1973-02-03 1974-10-14
JP2528652B2 (en) * 1987-03-30 1996-08-28 エスエス製薬株式会社 Long-acting cefradine formulation
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
JPH07267850A (en) * 1994-03-28 1995-10-17 Eisai Co Ltd Medicine composition prevented in unpleasant taste and method for producing the same
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
JP2000169364A (en) * 1998-09-30 2000-06-20 Taisho Pharmaceut Co Ltd Granule for oral pharmaceutical preparation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019486A1 (en) * 1990-06-14 1991-12-26 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
US5707646A (en) * 1992-03-12 1998-01-13 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition
EP0826376A1 (en) * 1995-05-02 1998-03-04 Taisho Pharmaceutical Co. Ltd Composition for oral administration
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
WO2000054811A1 (en) * 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
WO2000069415A2 (en) * 1999-05-19 2000-11-23 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Melt granulation

Also Published As

Publication number Publication date
MXPA03003146A (en) 2004-12-06
WO2002038577A3 (en) 2002-09-19
WO2002038577A2 (en) 2002-05-16
EP1333807A2 (en) 2003-08-13
JP2004528272A (en) 2004-09-16
AU2002239232A1 (en) 2002-05-21
CA2425688A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
IL152783A0 (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
IL145256A0 (en) Erythromycin derivatives
IL155103A0 (en) Substituted c-cyclohexylmethylamine derivatives
IL150557A0 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
IL155106A0 (en) Substituted 1-aminobutan-3-ol derivatives
PL356565A1 (en) Aminosulfonylbiphenyl derivatives
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
EP1333807A4 (en) Extended release erythromycin derivatives
AU2163202A (en) 5-amino-1-pentene-3-ol substituted derivatives
IL151598A0 (en) 2-phenylpyran-4-one derivatives
GB0025687D0 (en) Macrolides
GB0031306D0 (en) Macrolides
GB0031313D0 (en) Macrolides
GB0025691D0 (en) Macrolides
GB0025685D0 (en) Macrolides
GB0025689D0 (en) Macrolides
GB0025683D0 (en) Macrolides
GB0031314D0 (en) Macrolides
GB0031309D0 (en) Macrolides
GB0031311D0 (en) Macrolides
HK1054937A1 (en) 1-Methylcarbapenem derivatives
GB0021639D0 (en) Maurotoxin derivatives
SI1246793T1 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030509

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RUDNIC, EDWARD, M.

Inventor name: TREACY, DONALD, J., JR.

Inventor name: WASSINK, SANDRA, E.

A4 Supplementary search report drawn up and despatched

Effective date: 20050518

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/7048 B

Ipc: 7A 61K 47/14 B

Ipc: 7A 61K 47/10 B

Ipc: 7A 61K 47/02 B

Ipc: 7A 61K 9/22 B

Ipc: 7A 61K 9/20 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050803